Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer

Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.
Latest website image capture
Clouds background image

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new version entry on 2025-12-05 updates the Study Status in the record history, reflecting a change in the trial's current status.
    Difference
    0.1%
    Check dated 2025-12-08T22:51:00.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A new revision label v3.3.2 was added and the previous v3.2.0 label was removed. No study data or page functionality are affected.
    Difference
    0.0%
    Check dated 2025-11-24T17:05:44.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a new 'Study Status' entry in the history to reflect an updated trial status, and a separate content update labeled '111'. A government funding notice was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-17T15:05:29.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Newer record versions were added to the Record History, expanding the list of updates. No substantive changes to the study’s core content or trial details are visible.
    Difference
    0.0%
    Check dated 2025-11-03T01:30:22.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a new date entry and a study status line, and removed an older date entry. This indicates an updated time-stamped status update rather than changes to core content or pricing.
    Difference
    0.6%
    Check dated 2025-10-12T14:49:35.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and guidance for users.
    Difference
    7%
    Check dated 2025-10-05T10:23:44.000Z thumbnail image

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer

Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.